Download full-text PDF |
Source |
---|
Cornea
September 2024
Department of Corneal and External Eye Diseases, Moorfields Eye Hospital, London, United Kingdom.
Purpose: Acanthamoeba keratitis (AK) is a rare infection affecting the cornea. Immune-mediated sclerokeratitis is a well-documented late complication often requiring systemic immunosuppression. We present an alternative clinical presentation of subconjunctival abscesses caused by direct invasion of the Acanthamoeba and a proposed management strategy.
View Article and Find Full Text PDFExp Clin Transplant
July 2024
>From the Department of Ophthalmology, Ege University Faculty of Medicine, Izmir, Turkey.
Oman J Ophthalmol
June 2024
RP Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
BMJ Case Rep
June 2024
Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Scleromalacia perforans, or necrotising anterior scleritis, is a rare and severe form of eye disease that usually occurs in patients suffering from long-standing systemic inflammatory diseases, with rheumatoid arthritis (RA) being the most common. Here, we report the case of a patient who presented with redness of the eye and discolouration of the sclera and was diagnosed with scleromalacia perforans without any further extraophthalmic systemic involvement. Serological workup revealed highly positive cyclic citrullinated peptide (CCP) antibody (CCP-IgG/anticitrullinated protein antibodies) and positive rheumatoid factor, serologies commonly associated with RA.
View Article and Find Full Text PDFClin Ophthalmol
June 2024
John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
To review the latest surgical advances and evolving clinical use of scleral bio-tissue for reinforcement in the eye and review the published literature on novel surgical applications of scleral allograft bio-tissue. Conventional surgical procedures for scleral reinforcement using homologous scleral allograft have been traditionally ab-externo interventions comprising of anterior or posterior reinforcement of the sclera for clinical indications such as trauma, scleromalacia, glaucoma drainage device coverage, scleral perforation, buckle repair as well as posterior reinforcement for pathologic myopia and staphyloma. There have been a few novel ab-interno uses of scleral bio-tissue for reinforcement in both retina and glaucoma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!